Showing results (251-260 of 6,503) with videos related to
Sort By:
Pageof 651
Experimental Hematology|February 26, 2005
Role of VLA-4 and VLA-5 in ex vivo maintenance of human and pig hematopoiesis in human stroma-supported long-term culturesMaria A Giovino, Hui Wang, Megan Sykes, et al.Experimental Hematology|June 9, 2004
Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cellsAlan F List, Betty Glinsmann-Gibson, Chad Stadheim, et al.Experimental Hematology|June 9, 2004
Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectorsRoland Schroers, York Hildebrandt, Justin Hasenkamp, et al.Experimental Hematology|June 9, 2004
Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID miceToni Peled, Efrat Landau, Julie Mandel, et al.Experimental Hematology|March 9, 2004
Negative regulation of gamma-globin gene expression by cyclic AMP-dependent pathway in erythroid cellsAkio Inoue, Yuichi Kuroyanagi, Kiminori Terui, et al.Experimental Hematology|March 9, 2004
Initial human myeloid/dendritic cell progenitors identified by absence of myeloperoxidase protein expressionWalter Scholz, Barbara Platzer, Angela Schumich, et al.Experimental Hematology|August 17, 2004
Increased adhesive properties of eosinophils in sickle cell diseaseAndreia Averci Canalli, Nicola Conran, André Fattori, et al.Experimental Hematology|August 17, 2004
A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantationSoumya Panigrahi, Shoshana Morecki, Elena Yacovlev, et al.Experimental Hematology|August 17, 2004
G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditionsBerta Fuste, Gines Escolar, Pedro Marin, et al.Experimental Hematology|April 23, 2004
Acute myeloid leukemia cells in G0 phase of the cell cycle that are unresponsive to conventional chemotherapy are sensitive to treatment with granulocyte-macrophage colony-stimulating factor/diphtheria toxin fusion proteinsInge Jedema, Renée M Y Barge, Arthur E Frankel, et al.Pageof 651